A novel BACE-1 inhibitor discovered using eHiTS
It always feels good, when your product is successful in the hands of the end users, even more so when it comes to scientific software, and drug discovery.
A new article in Elsevier’s Bioorganic & Medicinal Chemistry Letters describes how researchers at the University of Leeds discovered novel non-peptide leads for β-secretase (BACE-1) - one of the key enzymes involved in the pathogenesis of Alzheimer’s disease, and a major target for drug discovery.
It is particularly exciting for us to know that our tools may play an instrumental role in finding a cure for a disease that affects so many beloved people in our lives.
The paper:
Discovery of novel non-peptide inhibitors of BACE-1 using virtual high-throughput screening
Bioorganic & Medicinal Chemistry Letters, Volume 19, Issue 23, 1 December 2009, Pages 6770-6774
N. Yi Mok, James Chadwick, Katherine A.B. Kellett, Nigel M. Hooper, A. Peter Johnson, Colin W.G. Fishwick
See this and other case studies with eHiTS at the SimBioSys’ User Publication pages: http://www.simbiosys.ca/science/user_pubs/index.html